|
|
|
Insider
Information: |
Labrucherie Gil M |
Relationship: |
Chief Financial Officer |
City: |
San Carlos |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
319,155 |
|
Indirect Shares
|
94,335 |
|
|
Direct
Value |
$377,825 |
|
|
Indirect Value
|
$460,355 |
|
|
Total
Shares |
413,490 |
|
|
Total
Value |
$838,179 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nektar Therapeutics |
NKTR |
SVP, COO & CFO |
2022-05-16 |
312,905 |
2008-11-14 |
0 |
Premium* |
|
Rezolute, Inc |
RZLT |
Director |
2022-05-04 |
0 |
2022-05-04 |
53,572 |
Premium* |
|
Acelyrin, Inc. |
SLRN |
Chief Financial Officer |
2023-10-04 |
6,250 |
2023-10-04 |
40,763 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
104 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2018-05-02 |
4 |
AS |
$85.63 |
$2,568,900 |
D/D |
(30,000) |
99,739 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2018-05-03 |
4 |
OE |
$10.69 |
$320,700 |
D/D |
30,000 |
129,739 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2018-05-03 |
4 |
AS |
$82.86 |
$2,485,800 |
D/D |
(30,000) |
99,739 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2018-05-16 |
4 |
S |
$83.39 |
$412,030 |
D/D |
(4,941) |
94,798 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
121,266 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2018-08-16 |
4 |
D |
$58.40 |
$479,289 |
D/D |
(8,207) |
113,059 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2018-11-16 |
4 |
S |
$38.25 |
$249,199 |
D/D |
(6,515) |
106,544 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2018-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
28,750 |
135,294 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-02-19 |
4 |
S |
$42.39 |
$152,265 |
D/D |
(3,592) |
131,702 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-05-16 |
4 |
S |
$31.37 |
$118,171 |
D/D |
(3,767) |
127,935 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-06-17 |
4 |
OE |
$7.21 |
$180,250 |
D/D |
25,000 |
152,935 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-06-17 |
4 |
AS |
$33.71 |
$842,750 |
D/D |
(25,000) |
127,935 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-07-10 |
4 |
AS |
$34.57 |
$864,250 |
D/D |
(25,000) |
127,935 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-07-10 |
4 |
OE |
$7.21 |
$180,250 |
D/D |
25,000 |
152,935 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-08-14 |
4 |
OE |
$7.21 |
$180,250 |
D/D |
25,000 |
152,935 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-08-14 |
4 |
AS |
$17.79 |
$444,750 |
D/D |
(25,000) |
127,935 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-08-16 |
4 |
S |
$18.15 |
$91,893 |
D/D |
(5,063) |
122,872 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-08-26 |
4 |
OE |
$16.31 |
$489,300 |
D/D |
30,000 |
152,872 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-09-16 |
4 |
AS |
$20.52 |
$513,000 |
D/D |
(25,000) |
152,872 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP & Chief Financial Officer |
|
2019-09-16 |
4 |
OE |
$7.21 |
$180,250 |
D/D |
25,000 |
177,872 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2019-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
227,872 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2019-10-15 |
4 |
OE |
$7.21 |
$180,250 |
D/D |
25,000 |
252,872 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2019-10-15 |
4 |
AS |
$15.83 |
$395,750 |
D/D |
(25,000) |
227,872 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2019-11-13 |
4 |
OE |
$7.21 |
$180,250 |
D/D |
25,000 |
252,872 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
SVP, COO & CFO |
|
2019-11-13 |
4 |
AS |
$19.79 |
$494,750 |
D/D |
(25,000) |
227,872 |
0 |
- |
|
104 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|